Paper23698397
Suppression of coronavirus replication by cyclophilin inhibitors.
Tanaka Y and 2 others. Viruses, 2013. Cited by 126 papers, by iCite.
Cite this record
ConductScience Library. Suppression of coronavirus replication by cyclophilin inhibitors. Papers, record 23698397. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/23698397
- Disease
- COVID-19540 drugs
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Connected records1
Records in the library's other databases whose lists name this one, each read from that database's own release: up to 20 of each kind, the most connected first.
Topics6
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Antiviral Agents | Major topic |
| Coronavirus | Major topic |
| Cyclophilins | Major topic |
| Cyclosporine | Major topic |
| Host-Pathogen Interactions | Major topic |
| Virus Replication | Major topic |
Source PubMed
Trials1
The trials whose ClinicalTrials.gov record lists the paper, and the trial numbers the paper's PubMed record names.
| Trial | Title | The trial lists it as | Named in the paper's record |
|---|---|---|---|
| NCT04540926 | Cyclosporine A Plus Low-steroid Treatment in COVID-19 Pneumonia | Results |
Source ClinicalTrials.gov
References48
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 15688292 | Function of HAb18G/CD147 in invasion of host cells by severe acute respiratory syndrome coronavirus. | J Infect Dis | 2005 | https://conductscience.org/library/papers/15688292 | PubMed |
| 2 | 16051301 | Mutagenesis of the murine hepatitis virus nsp1-coding region identifies residues important for protein processing, viral RNA synthesis, and viral replication. | Virology | 2005 | https://conductscience.org/library/papers/16051301 | PubMed |
| 3 | 18667415 | The mitochondrial phosphate carrier interacts with cyclophilin D and may play a key role in the permeability transition. | J Biol Chem | 2008 | https://conductscience.org/library/papers/18667415 | PubMed |
| 4 | 19932913 | Multiple cyclophilins involved in different cellular pathways mediate HCV replication. | Virology | 2010 | https://conductscience.org/library/papers/19932913 | PubMed |
| 5 | 22814107 | Cyclophilin A and viral infections. | Biochem Biophys Res Commun | 2012 | https://conductscience.org/library/papers/22814107 | PubMed |
| 6 | 20510744 | Contribution of Cyclophilin A to determination of simian immunodeficiency virus tropism: a progress update. | Vaccine | 2010 | https://conductscience.org/library/papers/20510744 | PubMed |
| 7 | 17696607 | Coronavirus non-structural protein 1 is a major pathogenicity factor: implications for the rational design of coronavirus vaccines. | PLoS Pathog | 2007 | https://conductscience.org/library/papers/17696607 | PubMed |
| 8 | 21752960 | Cyclosporin A inhibits the replication of diverse coronaviruses. | J Gen Virol | 2011 | https://conductscience.org/library/papers/21752960 | PubMed |
| 9 | 19430490 | Coronaviruses post-SARS: update on replication and pathogenesis. | Nat Rev Microbiol | 2009 | https://conductscience.org/library/papers/19430490 | PubMed |
| 10 | 12810862 | Requirement for cyclophilin A for the replication of vesicular stomatitis virus New Jersey serotype. | J Gen Virol | 2003 | https://conductscience.org/library/papers/12810862 | PubMed |
| 11 | 17715225 | Severe acute respiratory syndrome coronavirus evades antiviral signaling: role of nsp1 and rational design of an attenuated strain. | J Virol | 2007 | https://conductscience.org/library/papers/17715225 | PubMed |
| 12 | 8421688 | A cyclophilin-related protein involved in the function of natural killer cells. | Proc Natl Acad Sci U S A | 1993 | https://conductscience.org/library/papers/8421688 | PubMed |
| 13 | 9570313 | The 20kD protein of human [U4/U6.U5] tri-snRNPs is a novel cyclophilin that forms a complex with the U4/U6-specific 60kD and 90kD proteins. | RNA | 1998 | https://conductscience.org/library/papers/9570313 | PubMed |
| 14 | 7884893 | Mode of action of SDZ NIM 811, a nonimmunosuppressive cyclosporin A analog with activity against human immunodeficiency virus (HIV) type 1: interference with HIV protein-cyclophilin A interactions. | J Virol | 1995 | https://conductscience.org/library/papers/7884893 | PubMed |
| 15 | 11943775 | Active site residues of cyclophilin A are crucial for its signaling activity via CD147. | J Biol Chem | 2002 | https://conductscience.org/library/papers/11943775 | PubMed |
| 16 | 20962430 | Cyclophilin A: promising new target in cardiovascular therapy. | Circ J | 2010 | https://conductscience.org/library/papers/20962430 | PubMed |
| 17 | 21295323 | Emerging picture of host chaperone and cyclophilin roles in RNA virus replication. | Virology | 2011 | https://conductscience.org/library/papers/21295323 | PubMed |
| 18 | 22546085 | Suppression of feline coronavirus replication in vitro by cyclosporin A. | Vet Res | 2012 | https://conductscience.org/library/papers/22546085 | PubMed |
| 19 | 15579090 | Antiviral drugs that target cellular proteins may play major roles in combating HIV resistance. | Curr Pharm Des | 2004 | https://conductscience.org/library/papers/15579090 | PubMed |
| 20 | 15989969 | Cyclophilin B is a functional regulator of hepatitis C virus RNA polymerase. | Mol Cell | 2005 | https://conductscience.org/library/papers/15989969 | PubMed |
Cited by108
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 126 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 41702946 | Effectiveness and safety of cyclosporine A in moderate to severe COVID-19: a randomized, open-label trial. | Sci Rep | 2026 | https://conductscience.org/library/papers/41702946 | PubMed |
| 40867689 | Translating Antiviral Therapies to Veterinary Use: A Review of Immunomodulatory Agents for Potential Application in Aleutian Mink Diseases. | Animals (Basel) | 2025 | https://conductscience.org/library/papers/40867689 | PubMed |
| 39274454 | Cyclosporin A as an Add-On Therapy to a Corticosteroid-Based Background Treatment in Patients with COVID-19: A Multicenter, Randomized Clinical Trial. | J Clin Med | 2024 | https://conductscience.org/library/papers/39274454 | PubMed |
| 39045055 | Cyclophilin inhibition as a strategy for the treatment of human disease. | Front Pharmacol | 2024 | https://conductscience.org/library/papers/39045055 | PubMed |
| 38313994 | A Retrospective and Comparative Analysis of Clinical Outcomes of Kidney Transplant Recipients During First and Second COVID-19 Waves in North-West India. | Cureus | 2024 | https://conductscience.org/library/papers/38313994 | PubMed |
| 38287815 | Potential Alternative Receptors for SARS-CoV-2-Induced Kidney Damage: TLR-4, KIM-1/TIM-1, and CD147. | Front Biosci (Landmark Ed) | 2024 | https://conductscience.org/library/papers/38287815 | PubMed |
| 37766254 | Feline Infectious Peritonitis: European Advisory Board on Cat Diseases Guidelines. | Viruses | 2023 | https://conductscience.org/library/papers/37766254 | PubMed |
| 37742314 | A brief overview of SARS-CoV-2 infection and its management strategies: a recent update. | Mol Cell Biochem | 2024 | https://conductscience.org/library/papers/37742314 | PubMed |
| 37304177 | The Impact of Immune-Modulating Treatments for Dermatological Diseases on the Risk of Infection with SARS-CoV-2 and Outcomes Associated with COVID-19 Illness. | Curr Dermatol Rep | 2023 | https://conductscience.org/library/papers/37304177 | PubMed |
| 36986883 | An Enhanced Dissolving Cyclosporin-A Inhalable Powder Efficiently Reduces SARS-CoV-2 Infection In Vitro. | Pharmaceutics | 2023 | https://conductscience.org/library/papers/36986883 | PubMed |
| 36712291 | Cyclophilin A-mediated mitigation of coronavirus SARS-CoV-2. | Bioeng Transl Med | 2023 | https://conductscience.org/library/papers/36712291 | PubMed |
| 36531832 | Hepatic Disorders and COVID-19: From Pathophysiology to Treatment Strategy. | Can J Gastroenterol Hepatol | 2022 | https://conductscience.org/library/papers/36531832 | PubMed |
| 36187879 | Liver transplantation during COVID-19: Adaptive measures with future significance. | World J Transplant | 2022 | https://conductscience.org/library/papers/36187879 | PubMed |
| 36062268 | Impact of Living Donor Liver Transplantation on COVID-19 Clinical Outcomes from a Quaternary Care Centre in Delhi. | J Clin Transl Hepatol | 2022 | https://conductscience.org/library/papers/36062268 | PubMed |
| 36051937 | Immunomodulatory therapy for the management of critically ill patients with COVID-19: A narrative review. | World J Crit Care Med | 2022 | https://conductscience.org/library/papers/36051937 | PubMed |
| 35663540 | Pediatric transplantation during the COVID-19 pandemic. | World J Transplant | 2022 | https://conductscience.org/library/papers/35663540 | PubMed |
| 35568446 | Calcineurin Inhibitors and COVID-19. | Reumatol Clin (Engl Ed) | 2022 | https://conductscience.org/library/papers/35568446 | PubMed |
| 35369023 | A Comparison Study of Coronavirus Disease 2019 Outcomes in Hospitalized Kidney Transplant Recipients. | Kidney360 | 2021 | https://conductscience.org/library/papers/35369023 | PubMed |
| 35187216 | Immunosuppression and SARS-CoV-2 Infection in Kidney Transplant Recipients. | Transplant Direct | 2022 | https://conductscience.org/library/papers/35187216 | PubMed |
| 34985368 | COVID-19: General Strategies for Herbal Therapies. | J Evid Based Integr Med | 2022 | https://conductscience.org/library/papers/34985368 | PubMed |
Genes14
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
Drugs1
The drugs whose trials, in the Pipelines release, list the paper.
| Drug | ChEMBL ID | The trials list it as | Trials | In Drugs and targets |
|---|---|---|---|---|
| CYCLOSPORINE | CHEMBL160 | Results | 1 | https://conductscience.org/library/drugs/CHEMBL160 |
Source ChEMBL
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Comments and corrections
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/23698397
GET https://conductscience.org/api/papers/v1/23698397/references?page=2